Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.2M Buy
241,530
+39,508
+20% +$4.47M 1.1% 17
2026
Q1
$22.5M Buy
202,022
+106,293
+111% +$12.6M 1.01% 29
2025
Q4
$12.9M Buy
+95,729
New +$10.4M 0.52% 49

Other funds holding ABVX

Readystate Asset Management's ABVX Position: Q2 2026 in Review

Readystate Asset Management increased its Abivax (ABVX) stake by 20% in Q2 2026, buying an estimated $4.47M and bringing the position to 241,530 shares worth $32.2M. The position accounts for 1.1% of the portfolio, ranked #17.

Readystate Asset Management first reported a position in ABVX in Q4 2025 and has held it in 3 quarters since. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Readystate Asset Management held 241,530 shares of Abivax worth $32.2M as of Q2 2026.
  • Readystate Asset Management bought 39,508 Abivax shares in Q2 2026, an estimated $4.47M.
  • Abivax made up 1.1% of Readystate Asset Management's portfolio in Q2 2026, its #17 holding.
  • Readystate Asset Management first reported a position in Abivax in Q4 2025 and has held it in 3 quarters since.
  • 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Readystate Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.